Glaxo Ziagen
Executive Summary
University of Minnesota will receive royalties on abacavir of 5% for the first $300 mil. in worldwide sales, under the settlement of a licensing dispute. UM will receive 7% of sales from $300 mil. to $700 mil., and 10% of sales over $700 mil. annually. Total royalties could exceed $300 mil., the university estimates